📚 Central Nervous System Special Senses Module L4 Viral Infections Of The Cns

📚 Lecture Overview

This summary covers the primary viral pathogens affecting the Central Nervous System (CNS), including Herpes Simplex Virus (HSV-1 and HSV-2), Varicella-Zoster Virus (VZV), Measles, and the post-infectious condition Guillain-Barré Syndrome (GBS). It details viral structures, routes of entry, distinct clinical presentations, neuropathogenesis, diagnostic markers, and management strategies essential for exam mastery.

🎯 Key Concepts & Definitions

• Herpes Simplex Encephalitis (HSE): A life-threatening sporadic viral infection of the brain tissue, primarily caused by HSV-1 reactivation, localizing to the temporal lobe.
• Subacute Sclerosing Panencephalitis (SSPE): A chronic, fatal demyelinating CNS disease occurring years after a primary measles infection, caused by a mutant, defective virus.
• Ramsay Hunt Syndrome: A manifestation of reactivation of Varicella-Zoster Virus in the facial nerve, presenting with ear canal vesicles and ipsilateral facial palsy.
• Guillain-Barré Syndrome (GBS): A post-infectious, immune-mediated peripheral neuropathy characterized by symmetrical ascending weakness and loss of deep tendon reflexes.
• Albuminocytological Dissociation: A characteristic laboratory finding in GBS consisting of significantly elevated CSF protein with a normal CSF white blood cell count.

📖 Main Content

1. Classification & Entry Routes of CNS Viral Infections

Viruses gain access to the central nervous system via two primary routes (retrograde neuronal transport or hematogenous spread).

• Acute CNS Viral Infections:
  • Viral Meningitis (Aseptic): Caused mainly by Enteroviruses (coxsackievirus, echovirus, poliovirus), HSV-2, Mumps, Lymphocytic choriomeningitis virus (LCMV), and HIV.
  • Viral Encephalitis (Sporadic): Caused by HSV-1, VZV, Mumps, CMV, HHV-6, Rabies, and HIV.
  • Viral Encephalitis (Outbreaks): Caused by Polio/Enteroviruses, Measles (SSPE), JC virus, and Rubella.
• Chronic CNS Viral Infections:
  • Measles Subacute Sclerosing Panencephalitis (SSPE).
  • JC Virus: Causes Progressive Multifocal Leukoencephalopathy (PML).

2. Herpes Simplex Viruses (HSV-1 & HSV-2)

• Virus Properties: Large, enveloped viruses belonging to the Herpesviridae family (Alpha herpesvirus sub-family) that establish lifelong latent infections.
• Transmission: Direct close personal contact or sexual contact.
• Pathogenesis & Specificity:
  • HSV-1: Establishes latency in the trigeminal ganglia. Reactivation leads to retrograde/anterograde spread to the temporal lobe of the brain, causing sporadic fatal encephalitis in older children and adults.
  • HSV-2: Establishes latency in sacral/sensory ganglia. Causes aseptic meningitis in adults and diffuse encephalitis in neonates (acquired during vaginal delivery from mothers shedding HSV-2).
  • Cell Targets: Infects neurons, astrocytes, and oligodendrocytes. Pathological changes include severe necrosis, inflammation, and phagocytosis by glial cells (caused by both direct viral injury and immune-mediated responses).
• Clinical Presentation: Rapid onset of fever, headache, altered consciousness, and focal neurological signs.
• Diagnosis:
  • MRI: Key imaging modality showing localized destructive lesions in the temporal lobe.
  • CSF Analysis: Neutrophils present early (<48 hours), shifting to lymphocyte predominance after 48 hours. Moderately elevated protein; normal glucose.
  • PCR: The diagnostic test of choice for fast and specific detection of viral DNA in CSF.
  • Serology: Acute and convalescent serum pairs.
• Treatment: Immediate intravenous acyclovir and ganciclovir.

3. Varicella-Zoster Virus (VZV / HHV-3)

• Primary Infection (Varicella / Chickenpox):
  • Common childhood illness presenting with fever and a generalized, itchy (pruritic) but painless vesicular rash. Self-limiting.
• Reactivation (Herpes Zoster / Shingles):
  • Occurs in adults due to reactivation of latent VZV residing in dorsal root ganglia or cranial nerve ganglia.
  • Triggers: Immunosuppression, trauma, neoplastic diseases, or drugs.
  • Manifestations: Unilateral, extremely painful vesicular rash along dermatomes. The thoracic sensory nerves ("belt of roses from hell") and the ophthalmic/maxillary/mandibular divisions of the trigeminal nerve are most commonly affected.
• Ramsay Hunt Syndrome:
  • Involves reactivation in the facial nerve (CN VII).
  • Features: Vesicular rash on the tympanic membrane and external auditory canal paired with unilateral facial nerve palsy.
• Treatment & Prevention:
  • Chickenpox: Symptomatic treatment; prevented via the chickenpox vaccine.
  • Zoster: Antiviral therapy using acyclovir or vidarabine (inhibits viral DNA replication).

4. Measles Virus & Subacute Sclerosing Panencephalitis (SSPE)

• Viral Characteristics: Single-stranded RNA virus in the Paramyxoviridae family. Genetically stable; humans are the only natural host.
• Structural Composition: 6 structural proteins (3 complexed with viral RNA forming the nucleocapsid; 3 in the viral envelope).
• CNS Manifestations:
  1. Primary Measles Encephalitis: Occurs within 2 weeks of rash onset.
  2. Measles Inclusion Body Encephalitis: Subacute post-infectious course.
  3. Subacute Sclerosing Panencephalitis (SSPE): Late chronic degenerative disease.
• SSPE Pathogenesis:
  • Caused by persistent infection with a defective measles virus possessing mutations in the M (matrix) gene.
  • Defective M protein fails to interact properly with surface proteins (H and F), suppressing normal viral budding/release.
  • This forces direct cell-to-cell fusion, enabling the defective virus to spread surreptitiously and establish persistent infection in brain tissue, leading to widespread demyelination.
• SSPE Clinical Course:
  • Latency period of 2 to 10 years following primary infection (most common in children infected with measles before 2 years of age).
  • Progression: Personality changes → myoclonic seizures → severe motor disturbances → coma and death.
• Diagnosis: Extremely high titers of measles-specific antibodies in both serum and CSF.

5. Guillain-Barré Syndrome (GBS)

• Etiology: A post-infectious, immune-mediated peripheral neuropathy.
• Pathogenesis:
  • Driven by molecular mimicry.
  • Triggered 1–4 weeks prior by respiratory or gastrointestinal tract infections.
  • Key Pathogen: Campylobacter jejuni (most common cause).
  • Other Pathogens: Cytomegalovirus (CMV), Epstein-Barr Virus (EBV), Mycoplasma pneumoniae, Haemophilus influenzae, and Influenza A virus.
  • Immune response generates cross-reactive antibodies that attack gangliosides on nerve cell membranes.
• Clinical Features:
  • Rapidly progressive, symmetrical weakness starting in lower limbs and ascending.
  • Hyporeflexia or areflexia (absent deep tendon reflexes).
  • Sensory disturbances (numbness, paresthesias) and potential cranial nerve involvement.
• Diagnosis:
  • CSF Analysis: Albuminocytological dissociation (markedly elevated protein level with a normal white blood cell count).
  • Serological testing for antiganglioside antibodies.
• Management:
  • Intravenous Immunoglobulin (IVIg) or Plasma Exchange (Plasmapheresis).
  • Supportive medical care (monitoring respiratory function).

📊 Visual Learning

💡 Important Points to Remember

• HSV-1 is the leading cause of sporadic fatal encephalitis worldwide; it selectively damages the temporal lobe.
• HSV-2 is primarily linked to viral meningitis in adults and diffuse encephalitis in neonates acquiring the virus via vaginal delivery.
• HSE CSF Findings: Early neutrophils (<48h), late lymphocytes (>48h), high protein, and normal glucose.
• VZV Latency: Resides in dorsal root ganglia or cranial nerves; reactivation along thoracic sensory nerves causes classic unilateral zoster ("belt of roses from hell").
• Ramsay Hunt Syndrome: Triad of facial nerve palsy, ear canal vesicular rash, and tympanic membrane involvement.
• SSPE Mechanism: Caused by a mutated M (matrix) gene in the measles virus, suppressing viral particle release and accelerating cell-to-cell fusion.
• SSPE Timeline: Onset occurs 2–10 years post-measles infection, primarily in children infected under 2 years of age.
• GBS Hallmark: Albuminocytological dissociation (high CSF protein, completely normal WBC count).
• GBS Trigger: Campylobacter jejuni is the most common antecedent pathogen inducing ganglioside-directed molecular mimicry.
• GBS Clinical Signs: Symmetrical, ascending flaccid paralysis paired with hyporeflexia or areflexia.

⚠️ Common Exam Questions & Traps

Common Exam Traps & MCQ Tricks:

1. CSF Diagnostic Traps:
   - Trap: Questions presenting elevated CSF protein and normal glucose to trick you into choosing bacterial meningitis.
   - Rule: Check the cell count! High protein + normal WBC count = GBS (Albuminocytological dissociation). High protein + lymphocytosis = Viral encephalitis/meningitis.
2. HSV Type Confusion:
   - Trap: Examiners swap HSV-1 and HSV-2 manifestations.
   - Rule: HSV-1 = Encephalitis (Temporal lobe, older kids/adults). HSV-2 = Meningitis (Adults) OR Diffuse Encephalitis (Neonates).
3. Measles SSPE Gene Mutations:
   - Trap: MCQs listing surface glycoproteins (H or F) as defective in SSPE.
   - Rule: The mutation specifically affects the M (Matrix) protein, which impairs transport of H and F to the viral release site.
4. Guillain-Barré Syndrome Management:
   - Trap: Offering antibiotics or corticosteroids as first-line treatment for GBS following C. jejuni infection.
   - Rule: GBS is an immune-mediated post-infectious process. Active infection is already gone; treatment must be IVIg or Plasma Exchange.
5. Pain Assessment in Rash:
   - Trap: Differentiating Varicella (Chickenpox) from Zoster (Shingles) clinical presentations.
   - Rule: Varicella rash is itchy and painless. Zoster rash is intensely painful.

📝 Quick Review Checklist

I can differentiate the clinical presentations and primary ganglionic sites of HSV-1 vs. HSV-2.
I can recall the specific CSF profile of Herpes Simplex Encephalitis (lymphocyte predominance, normal glucose, high protein).
I can explain the anatomical involvement and clinical features of Ramsay Hunt Syndrome.
I can detail the molecular defect (M protein mutation) causing persistent measles infection in SSPE.
I can define "molecular mimicry" and name the primary GI pathogen (C. jejuni) triggering GBS.
I can identify the diagnostic CSF signature of GBS (albuminocytological dissociation).
I know the correct treatments for HSE (IV acyclovir), VZV (acyclovir/vidarabine), and GBS (IVIg/plasma exchange).